Neurofibromatosis type 2: Report of a family and review of current evaluation and treatment
Authors:
- 1 February 1991
- journal article
- case report
- Published by Wiley in The Laryngoscope
- Vol. 101 (2) , 109-113
Abstract
Significant advances during the past decade have greatly improved our understanding of neurofibromatosis type 2, a genetic disease which results in bilateral acoustic neuromas. The emergence of gadolinium-enhanced magnetic resonance imaging has allowed early detection of minute intracanalicular eighth-nerve tumors, less than 1 cm in diameter. Recombinant DNA studies have clarified the genetics that underlie neurofibromatosis type 2 and separate it from a variety of related conditions, such as von Recklinghausen's neurofibromatosis. Early diagnosis and surgical removal of these tumors may offer the only hope of preserving hearing and facial nerve function. A report of the evaluation and treatment of a family with multiple affected individuals will exemplify these conclusions.Keywords
This publication has 10 references indexed in Scilit:
- Multiple‐Channel Stimulation of the Cochlear NucleusOtolaryngology–Head and Neck Surgery, 1989
- Neurofibromatosis 2: Clinical and DNA Linkage Studies of a Large KindredNew England Journal of Medicine, 1988
- NeurofibromatosisNeurologic Clinics, 1987
- Acoustic neuroma surgery: The results of hearing conservation surgeryThe Laryngoscope, 1987
- Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor geneCell, 1987
- Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17Science, 1987
- Management of bilateral acoustic tumors.The Laryngoscope, 1982
- Bilateral Acoustic Tumors: A Diagnostic and Surgical ChallengeJAMA Otolaryngology–Head & Neck Surgery, 1980
- Central neurofibromatosis with bilateral acoustic neuromaNeurology, 1980
- BRAIN STEM EVOKED RESPONSE AUDIOMETRY IN A CLINICAL PRACTICEThe Laryngoscope, 1979